Oct 26, 2021Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary ObjectiveJERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Oct 12, 2021Meet Alpha Tau at ASTRO Chicago 2021We are thrilled to announce that the Alpha Tau team will be attending (IN PERSON this year - Finally ! ) the ASTRO conference in Chicago....
Oct 12, 2021Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBMJERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to...